Comparison

Amplatzer™ Portfolio vs ROTEM

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Amplatzer™ Portfolio

This medical app assists healthcare professionals in selecting appropriate structural intervention devices based on patient defect information. It provides up-to-date device availability and works offline on smartphones and tablets.

Highlights
  • Suggests devices based on defect information
  • Works offline
  • Accessible on smartphones and tablets
  • Always up to date
  • Shows available devices in your region
Read full description

The Abbott™ Amplatzer™ Structural Intervention devices offer a broad portfolio with a relentless focus on advancing patient safety. After two decades of clinical success, it remains the leader in innovation and treatment worldwide. Now, we want to make it even easier to use these devices. With the Amplatzer™ Portfolio App, you enter defect information based on imaging and the app suggests applicable devices based on the IFU. It’s free and works on both smartphones and tablets, even when you’re offline. Amplatzer™ portfolio - Always up to date - Shows every device available in your region - Accessible online and offline - Works on smartphones and tablets

About

ROTEM

Features
Read full description

ROTEM (rotational thromboelastometry) is a point-of-care viscoelastic test that evaluates coagulation in real time using whole blood, rather than just providing an isolated number like PT or aPTT. In just a few minutes, it shows how the clot forms, how firm it is, and whether it degrades, through its channels (EXTEM, INTEM, FIBTEM, APTEM, HEPTEM) and parameters (CT, CFT, A5/A10, MCF, ML). It is a key tool for guiding transfusion therapy in trauma, cardiac surgery, postpartum hemorrhage, and severe perioperative bleeding. The problem: ROTEM provides a lot of information quickly... but interpreting it under pressure, remembering normal ranges, and translating it into a concrete action plan isn't always easy, especially outside clinical areas where it is used daily. That’s where ROTEM Interpreter comes in. Enter the values from the terminal, and the app does the rest: Live temogram: As you type, the clot morphology for each channel is drawn—just as you see it on the device—connecting the numbers with the visual image to cement the pattern in your memory. Automatic interpretation: Identifies key patterns: hyperfibrinolysis, fibrinogen vs. platelet deficiency, factor deficiency, heparin effect, and hypercoagulability. Suggested action with dosing: Translates the findings into practical recommendations, calculating fibrinogen dosage (based on target A5 increase and body weight) and A5-guided platelet dosing. Step-by-step management algorithm: (EXTEM/FIBTEM) featuring zoom and pan capabilities for detailed exploration. Integrated guide: Test portfolio, diagnostic patterns, fibrinogen calculation, and an evidence and guidelines section (Cochrane, European Trauma Guideline, ESAIC, EACTS, NICE, OBS2) with links to the original sources. Device-saved interpretation history: 100% offline, light/dark modes, for both adult and pediatric profiles. Who is this for: Intensivists, anesthesiologists, emergency physicians, hematologists, and residents who want to interpret ROTEM quickly and confidently at the bedside. Decision support tool: This app does not replace clinical judgment or correlation with the patient's context; always verify against local ranges and protocols.

Screenshots

Amplatzer™ Portfolio4 screens
ROTEM4 screens

Verdict

The call

The clearest difference is price: Amplatzer™ Portfolio at Free against ROTEM's $2.99. Amplatzer™ Portfolio also leads on iOS requirement (12.0 vs 18.0). ROTEM's advantage is update cadence (every 3 weeks vs every 3 months). On ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Amplatzer™ Portfolio is free to download; ROTEM costs $2.99 up front. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

Amplatzer™ Portfolio ships an update every 3 months, ROTEM every 3 weeks. The most recent releases landed on October 23, 2026 and October 28, 2026 respectively.

Scorecard3 real differences · 6 level
Amplatzer™ Portfolio versus ROTEM: the parameters behind the verdict, then further details
ParameterAmplatzer™ PortfolioROTEM
PriceFree — better$2.99
Rating5.0 (16 ratings) — better—
Number of ratings16 — better—
Update frequencyEvery 3 monthsEvery 3 weeks — better
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPad, iPod — betteriPhone, iPad
Requires iOS12.0 — better18.0
Further details — not scored
Size36 MB4 MB
Age rating17+4+
DeveloperAbbottCarlos Sarta

In-app purchases

None

Amplatzer™ Portfolio

No in-app purchases

None

ROTEM

No in-app purchases

Questions

Is Amplatzer™ Portfolio free?
Amplatzer™ Portfolio is free to download, with no in-app purchases.
Is ROTEM free?
ROTEM costs $2.99, with no in-app purchases.
Do Amplatzer™ Portfolio or ROTEM have ads?
Neither Amplatzer™ Portfolio nor ROTEM shows ads.
Which is updated more often, Amplatzer™ Portfolio or ROTEM?
Amplatzer™ Portfolio ships an update every 3 months, and ROTEM every 3 weeks. Most recently, Amplatzer™ Portfolio was updated on October 23, 2026 and ROTEM on October 28, 2026.

Other comparisons